A significant OS advantage favoring RIC HSCT did emerge for this later period (5-year OS: 83% in RIC and 47% in MAC, p=0.003; Table 3 , Figure 1A ), with a suggestion of a difference in PFS which did not reach statistical significance (64% in RIC and 47% in MAC, p=0.15; Table 3 , Figure 1B ).
← all excerpts
Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome.
1
0.1500
0.1500